Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma.

作者: E. Emri , K. Egervari , T. Varvolgyi , D. Rozsa , E. Miko

DOI: 10.1111/J.1468-3083.2012.04653.X

关键词:

摘要: Background  The formation of metastases and the efficacy systemic therapies in cutaneous malignant melanoma (CMM) depend on characteristics tumour cells host immune response. Aberrant expression metallothionein (MT) has been observed several types cancers with poor prognoses. Objective  To perform an immunohistochemical study primary CMM comparing MT tumours without (n = 23) to that samples haematogenous examine correlation between staining immunological markers relevant progression. Methods  labelling different sections was analysed using tissue microarrays for evaluation suitability this method future studies. Results  Our results suggest overexpression is significantly more frequent (P = 0.018) independent Breslow thickness (R = 0.102, P = 0.501). Interestingly, correlated presence tumour-infiltrating CD68+ macrophages (P = 0.003), a known predictive factor progression, thereby suggesting role development defective Furthermore, CD163+ infiltrating metastasis (P < 0.001), whereas CD1a+ dendritic surrounding associated lower risk spread (P = 0.003). Conclusion  demonstrate may represent suitable prognostic can characterize metastasising ability tumour-promoting

参考文章(31)
Milena Penkowa, Adam Bohr, Allan Evald Nielsen, The Balance between Life and Death of Cells: Roles of Metallothioneins. Biomarker Insights. ,vol. 1, pp. 99- 111 ,(2006) , 10.4137/BMI.S0
Levi Fried, Jack L. Arbiser, The reactive oxygen-driven tumor : relevance to melanoma Pigment Cell & Melanoma Research. ,vol. 21, pp. 117- 122 ,(2008) , 10.1111/J.1755-148X.2008.00451.X
Olga M. Pena, Jelena Pistolic, Disha Raj, Christopher D. Fjell, Robert E. W. Hancock, Endotoxin Tolerance Represents a Distinctive State of Alternative Polarization (M2) in Human Mononuclear Cells Journal of Immunology. ,vol. 186, pp. 7243- 7254 ,(2011) , 10.4049/JIMMUNOL.1001952
David A Moore, J Howard Pringle, Gerald S Saldanha, Prognostic tissue markers in melanoma. Histopathology. ,vol. 60, pp. 679- 689 ,(2012) , 10.1111/J.1365-2559.2011.03910.X
William Vermi, Raffaella Bonecchi, Fabio Facchetti, Denise Bianchi, Silvano Sozzani, Silvana Festa, Angiola Berenzi, Marina Cella, Marco Colonna, Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. The Journal of Pathology. ,vol. 200, pp. 255- 268 ,(2003) , 10.1002/PATH.1344
Trine Ollegaard Jensen, Rikke Riber-Hansen, Henrik Schmidt, Stephen Jacques Hamilton-Dutoit, Torben Steiniche, Tumor and inflammation markers in melanoma using tissue microarrays: a validation study. Melanoma Research. ,vol. 21, pp. 509- 515 ,(2011) , 10.1097/CMR.0B013E32834A3899
Christian Bjørn Poulsen, Rehannah Borup, Niels Borregaard, Finn Cilius Nielsen, Michael Boe Møller, Elisabeth Ralfkiaer, Prognostic significance of metallothionein in B-cell lymphomas Blood. ,vol. 108, pp. 3514- 3519 ,(2006) , 10.1182/BLOOD-2006-04-015305
Effie Ablett, David C. Whiteman, Glen M. Boyle, Adèle C. Green, Peter G. Parsons, Induction of Metallothionein in Human Skin by Routine Exposure to Sunlight: Evidence for a Systemic Response and Enhanced Induction at Certain Body Sites Journal of Investigative Dermatology. ,vol. 120, pp. 318- 324 ,(2003) , 10.1046/J.1523-1747.2003.12025.X
Alexander M.M Eggermont, John M Kirkwood, Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? European Journal of Cancer. ,vol. 40, pp. 1825- 1836 ,(2004) , 10.1016/J.EJCA.2004.04.030